Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, vol.130, no.2, pp.125-133, 2022 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 130 Issue: 2
- Publication Date: 2022
- Doi Number: 10.1055/a-1523-7216
- Journal Name: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
- Page Numbers: pp.125-133
- Keywords: FGFR-4, Ki-67, pituitary adenomas, tumor aggressiveness
- Istanbul University Affiliated: Yes
Abstract
Purpose To investigate the relationship of Fibroblast Growth Factor Receptor-4 (FGFR-4) expression with radiologic, pathologic, and clinical parameters in pituitary adenomas.